| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $410K | -88.9% | -96.2% |
| R&D Expense | $32.5M | -2.9% | +24.0% |
| SG&A Expense | $13.6M | +10.6% | +7.0% |
| Operating Income | -$46.1M | -2.8% | -15.0% |
| Interest Expense | $3.1M | +1.0% | -8.7% |
| Income Tax | $0 | — | — |
| Net Income | -$50.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.8M | -53.9% | -87.9% |
| Accounts Receivable | $2.8M | +21.1% | -14.4% |
| Inventory | $385K | +22.6% | — |
| Current Assets | $34.2M | -27.4% | -75.4% |
| Total Assets | $189.5M | -4.7% | -36.7% |
| Current Liabilities | $152.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$93.0M | — | — |
| Capital Expenditures | $3.6M | — | — |
| Investing Cash Flow | -$3.0M | — | — |
| Financing Cash Flow | $6.9M | — | — |
| Free Cash Flow | -$96.5M | — | — |
| -28.4% |
| EPS (Basic) | -$0.62 | -29.2% | -12.7% |
| EPS (Diluted) | -$0.62 | -29.2% | -12.7% |
| +186.2% |
| +157.4% |
| Total Liabilities | $230.0M | +17.5% | +12.9% |
| Stockholders' Equity | -$40.6M | -1470.2% | -142.4% |